One of the most frustrating aspects of healthcare innovation is that a product can clearly solve a problem and still struggle to gain adoption.
I’ve seen organisations spend years developing solutions that clinicians genuinely liked, only to discover that enthusiasm alone was not enough to drive widespread uptake.
The assumption is often that adoption will naturally follow if the product is clinically sound.
Healthcare rarely works that way.
Adoption is influenced by organisational priorities, stakeholder interests, funding pressures, implementation requirements and risk perceptions. The product itself is only one part of a much larger equation.
Healthcare organisations are continually presented with new products, technologies and ideas.
Many of these innovations offer genuine benefits.
The challenge is that healthcare systems are not designed to adopt change quickly.
In fact, in many situations they are designed to do the opposite.
Healthcare providers manage risk, protect patient outcomes and maintain consistent standards of care. Any proposed change must compete against established practices that are already familiar, understood and accepted.
As a result, organisations are often being asked to evaluate not only whether an innovation is better, but whether the benefits justify the disruption required to implement it.
One of the biggest differences between healthcare and many other industries is the number of stakeholders involved in decision making.
A clinician may support the innovation.
A department manager may see operational benefits.
Procurement may focus on supplier considerations.
Finance teams may focus on budget impact.
Executives may prioritise broader organisational objectives.
Each stakeholder evaluates the opportunity through a different lens.
A compelling argument for one audience is not necessarily compelling for another.
Organisations that understand this dynamic are generally more successful at developing effective adoption strategies.
Healthcare professionals operate in environments where time and resources are limited.
Even relatively small changes to clinical workflows, administration processes or documentation requirements can create significant resistance.
This does not mean healthcare organisations reject innovation.
It means implementation effort becomes part of the adoption decision.
I’ve often found that products succeed more easily when they minimise disruption rather than requiring people to substantially change established behaviours.
The more naturally a product fits into existing workflows, the fewer barriers adoption teams need to overcome.
Clinical evidence remains essential.
However, evidence requirements often extend beyond safety and efficacy.
Healthcare organisations increasingly want to understand:
This creates a broader commercial challenge.
A product may demonstrate strong clinical outcomes yet still struggle if stakeholders cannot clearly understand the broader value proposition.
Generating the right evidence is often as important as generating more evidence.
Most successful healthcare innovations have something in common.
Someone inside the organisation believes strongly enough in the solution to help drive change.
These internal champions play an important role in:
Without strong internal advocates, even high-value innovations can struggle to gain momentum.
Identifying and supporting these stakeholders should be an important part of any commercial strategy.
Healthcare organisations rarely have unlimited resources.
Even when the benefits of a solution are recognised, budget constraints may delay or prevent adoption.
This can be particularly challenging when:
Understanding how funding decisions are made can often be just as important as understanding product performance.
Many organisations focus heavily on launch activities.
Awareness is generated.
Presentations are delivered.
Clinical data is shared.
Then attention shifts to the next objective.
Healthcare adoption rarely follows a linear path.
Implementation, training, engagement and ongoing support often have a greater influence on long-term success than launch activities alone.
Adoption should be viewed as an ongoing process rather than a single milestone.
Healthcare adoption barriers are rarely caused by a lack of innovation.
More often, they emerge from the realities of how healthcare organisations make decisions, manage risk and implement change.
The organisations that achieve stronger commercial outcomes are usually those that recognise adoption as a strategic challenge rather than simply a sales challenge.
Innovation is important.
Adoption is what ultimately determines whether that innovation creates meaningful impact.
Before asking:
“Why isn’t our product growing faster?”
it is often worth asking:
“What barriers are preventing people from changing what they do today?”